Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

FREYR Selects 24M as Technology Partner for Mass Production of the Most Cost-competitive, Environmentally Friendly and Safe Battery Cells

FREYR AS and 24M Technologies Inc. have signed a framework agreement for the in-licensing of the 24M lithium-ion cell manufacturing process and platform. FREYR plans to build, own and operate multiple lithium-ion battery (LiB) cell manufacturing facilities under development in Mo i Rana, Norway using the 24M semisolid electrode platform. The 24M technology provides the most space-efficient, lowest cost and modular manufacturing process for producing the most cost-competitive, environmentally friendly and safe battery cells. “FREYR is very excited to announce this first selection of a

Altor and Stena Adactum, through GB HoldCo, completes the offer to the shareholders of Gunnebo and GB HoldCo thereby becomes the owner of 94.5 percent of the shares [1] in Gunnebo

This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important information" at the end of this press release

AlzeCure publishes its interim report for January – September 2020

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the period January – September 2020 is now available on the company’s website: https://www.alzecurepharma.se/en/section/investors/financial-reports/“AlzeCure has had another productive quarter during which its operations progressed according to plan, with advances in all three of our project platforms: NeuroRestore, Alzstatin and Painless. Preparations to begin two additional clinical trials at the end of the year for the drug candidates ACD856 and ACD440 are proceeding according to plan.” Martin

Samut Songkram - a true sense of the charming local Thai

Samut Songkhram is tucked into a picturesque patch of coastline on the Gulf of Thailand. Located about an hour drive southwest of Bangkok, the uniqueness of this province is its location that combines 3 kinds of water; fresh water, brackish water and salt water. Despite its small size, Samut Songkhram offers numerous unique attractions. Here we give some tips that enhance your local travel experience.   Maeklong Railway Market - Thailand’s folding umbrella market At glance, many markets in Thailand look the same,

Scania invests in battery assembly plant

With the rapid expansion of Scania’s electrified range of trucks, buses and engines, the company plans to, over several years, invest well over 1 billion SEK in a battery assembly plant in Södertälje, Sweden. The initial step is a 18,000-square metre facility and the construction will start early 2021 with the aim to be fully operational by 2023."This is a tangible manifestation of our determination to take a leading role in heavy vehicle electrification, which is needed to fulfil our commitment to science-based climate targets,” says Ruthger de Vries, Head of Production and Logistics at

Inzile AB (publ) Interim Report 1 Januari - 30 September 2020

Third quarter 2020 in brief • Framework agreement was signed with Ramudden for initial delivery of six vehicles • Agreement was reached on the delivery of two additional vehicles to Picsmart • The Swedish Energy Agency selected Inzile for participation in feasibility study   regarding development of a combined battery and fuel cell system • Inzile raised SEK 32.7 million through redemption of warrants Third quarter in numbers • Net sales amounted to SEK 37.9 (0) thousand • Operating profit (EBIT) amounted to SEK -11.3 (-10.2) million • Result of for the period

Interim report January - September 2020

Third quarter 2020 · Revenues amounted to MSEK 494.8 (MSEK 282.6), an increase by 75 % compared to the same period last year. · Operating profit amounted to MSEK 187.7 (MSEK 93.1), an increase by 102 %. · Profit after financial items amounted to MSEK 187.0 (MSEK 92.9), and profit after tax amounted to MSEK 148.5 (MSEK 74.0). · Cash flow from operating activities amounted to MSEK 213.0 (MSEK 73.4), and cash flow from investing activities amounted to MSEK -236.4 (MSEK -32.5). · By the end of the period cash amounted to MSEK 600.0 (MSEK 434.6). · Earnings per share amounted

Herantis Pharma Announces Favorable 24-Month Follow-Up Review from Phase I Lymfactin® []Trial in Breast Cancer Associated Lymphedema

Key Highlights: · Safety and tolerability maintained through to 24 months · Clinically meaningful improvements after 12 months, maintained out to 24 months · Top-line data for follow on Phase II study expected in Q1 2021 after 12 months blinded follow-up Herantis Pharma Plc Company release, 17 November 2020 at 9:00 a.m. Eastern European Time Herantis Pharma Plc (“Herantis”), an innovative drug development company pioneering new disease modifying and regenerative biologic and gene therapies, today announced its novel gene therapy candidate Lymfactin®, a Vascular

Thunderful Group intends to list its shares on Nasdaq First North Premier Growth Market

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES.Thunderful Group AB (“Thunderful Group” or the “Company”), a primarily Nordic gaming group within development and publishing of games as well as distribution of Nintendo products, toys, and gaming accessories, today announces its intention to launch an initial public offering of its shares (the “Offering”) and to list

IRRAS Awarded Breakthrough Technology Purchasing Agreement with Premier for Hummingbird ICP Monitoring Products

· Premier is one of the leading healthcare improvement companies in the United States, uniting an alliance of approximately 4,100 US hospitals and 200,000 providers. · Hummingbird family of products are now available to Premier’s member facilities in the US as contracted items with pre-negotiated pricing and terms.Stockholm, November 17, 2020 – IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that its Hummingbird family of intracranial pressure (ICP) monitoring equipment has been awarded

Fortum January-September 2020 Interim Report: Seasonally weak Uniper quarter burdened Fortum’s results – Generation segment stable on good hedges

FORTUM CORPORATION JANUARY-SEPTEMBER 2020 INTERIM REPORT 17 NOVEMBER 2020 AT 9:00 EET This release is a summary of Fortum’s January-September 2020 Interim Report. The complete report is attached to this release as a pdf file. It is also available on the company's website at www.fortum.com/investors July-September 2020 · Comparable EBITDA was EUR 132 (295) million · Comparable operating profit was EUR -176 (153) million due to Uniper’s negative result in the third quarter · Operating profit was EUR 60 (124) million, impacted by a EUR 291 million sales gain from the

Hexagon Composites ASA: Notice of Written Resolution

Hexagon Composites ASA (“Hexagon”) has requested Nordic Trustee AS as Bond Trustee to issue a notice of written resolution in respect of its NOK 1,100,000,000 senior unsecured bond issue, HEX03 - ISIN NO0010846280 (the "Bond"), in the context of proposing certain amendments to the terms of the Bond as set out in the attached notice of the written resolution. The proposal is supported by a group of bondholders representing more than two-thirds of the notional amount. Carnegie AS and SEB are acting as financial advisors to Hexagon. For further queries, please contact: David

70% of KappAhl’s range is made of more sustainable materials

KappAhl’s efforts to contribute to a circular fashion industry are showing good results. At present, 70 per cent of the fashion chain’s range is comprised of more sustainable materials. Five years ago, this figure was 19 per cent, and the target of 100 per cent by 2025 is within reach.      “The percentage of more sustainable materials in our range is increasing and each year sees us moving measurably closer to our goal of creating a circular business,” says KappAhl’s CEO Elisabeth Peregi.Year by year, KappAhl is making measurable progress in its sustainability agenda. Its commitment to

Skanska builds new infrastructure at Los Angeles International Airport, California, USA, for USD 335 M, about SEK 2.9 billion

Skanska has signed a contract with Los Angeles World Airports (LAWA) to serve as the design-builder for the airport authority’s Roadways, Utilities and Enabling (RUE) project. The contract is worth USD 335 M, about SEK 2.9 billion, which will be included in the US order bookings for the fourth quarter of 2020.The RUE project supports the next phase of high-priority enabling work for LAWA’s Landside Access Modernization Program (LAMP), which aims to relieve congestion for people traveling to and from the third busiest airport in the world and second busiest in the U.S. This enabling work is

iioote Appoints Two New Board Members

IoT-company iioote welcomes two new board members, Jacob Hansen Karaduman, Enklare AB cofounder and serial tech entrepreneur with a demonstrated track record for advising, building, and rapidly scaling start-ups, and Oskar Boström, an entrepreneur with extensive experience in IoT and Robotics. Their knowledge and experience will play an important role in the company's expansion and development of innovative solutions. The Board already features broad competences in IoT, IT and telecommunications combined with sector-specific experience in construction, mechanical engineering,

Interim report 3, 2020 – Strong profitability and focus on AI as SaaS

Speqta AB (plc) Interim Report for quarter 3, 2020 has now been made public and is available at:https://speqta.com/en/investors/financial-reports Significant event during third quarter · Revenues increased by 72% to KSEK 43 746 (25 505). · EBITDA profit increased by 165% and amounted to KSEK 10 074 (3 804) an operating margin of 23% (17). · Sales in the C&C Segment increased by 170% and amounted to KSEK 30 773 (11 389). EBITDA, excluding management fee, increased by 68% to KSEK 11 521 (6 837). · Sales in the AdTech Segment amounted to KSEK 12 973 (14 112). EBITDA,

Musti Group plc – Managers' transactions – Rönnberg

Musti Group plc – Managers' transactions – Rönnberg Musti Group plc        Managers’ transactions      17 November 2020, at 8.00 a.m. EET Musti Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Rönnberg, David Position: Chief Executive Officer Issuer: Musti Group Oyj LEI: 743700IE9NQGF9YZAI97 Notification type: INITIAL NOTIFICATION Reference number: 743700IE9NQGF9YZAI97_20201116145346_9 ____________________________________________ Transaction date: 2020-11-16 Venue:

BERGENBIO ASA: THIRD QUARTER 2020 RESULTS

Bergen, Norway, 17 November 2020 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, announces its results for the third quarter of 2020. A presentation and live webcast by BerGenBio’s senior management will take place at 10.00 am CET today, please see below for details. Operational Highlights – third quarter of 2020 (including post-period end) Oncology · Primary endpoint met in BERGAMO Phase II Trial investigating bemcentinib in patients with High Risk Myelodysplastic

Targovax to present at Bryan Garnier & Co Virtual European Healthcare Conference

Oslo, 17 November 2020 – Targovax ASA, today announces that members of the management team will present the company at Bryan Garnier & Co Virtual European Healthcare Conference today, Tuesday 17 November.The presentation will be available to download at www.targovax.com  after the event. About the event The annual European Healthcare Conference is one of the top events organized by Bryan, Garnier & Co. By invitation only, it brings together industry leaders, emerging fast-growth companies, innovative technology creators and members of the

Flex LNG Q3, 2020 Earnings Release

November 17, 2020 – Hamilton, BermudaFlex LNG Ltd. (“Flex LNG” or the “Company”) today announced its unaudited financial results for the third quarter and nine months ended September 30, 2020. Highlights: · Revenues of $33.1 million for the third quarter 2020, compared to $25.8 million for the second quarter 2020. · Net income of $3.8 million and earnings per share of $0.07 for the third quarter 2020, compared to a net loss of $6.7 million and loss per share of $0.12 for the second quarter 2020. · Average Time Charter Equivalent (“TCE”) rate of $46,569 per day for the third

There are no items matching the current filter
There are no more items matching the current filter
Back to top